Concepedia

Author

Jan J. Cornelissen

Erasmus MC Cancer InstituteORCID

Also Known As

A Sureda, Cornelissen, Jan, Didier Blaise, Edouard Forcade, Fernanda Volt, Georgia Cook, Gerard Socié, J Cornelissen, J J Cornelissen, J. Cornelissen

610

Publications

31.5K

Citations

78

H-Index

170

Concepts

All Affiliations

Erasmus MC Cancer InstituteErasmus MCSorbonne UniversitéHôpital Saint-AntoineSheba Medical Center
JJ

About

Jan J. Cornelissen is an author at Erasmus MC Cancer Institute specializing in medicine, hematology, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

41

115

6.7K

2

Health Sciences

24

41

2.2K

3

Public Health

5

5

399

4

Engineering

1

1

13

5

Natural Sciences

1

1

21

Jan J. Cornelissen

×

261

Publications

27.5K

Citations

75

H-Index

YearCitations

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Stephen G. O’Brien, François Guilhot, Richard A. Larson,

New England Journal of Medicine

2003

3.5K

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Brian Druker, François Guilhot, Stephen G. O’Brien,

New England Journal of Medicine

2006

3.5K

Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

Jeroen J. A. van Kampen, David van de Vijver, Pieter L. A. Fraaij,

Nature Communications

2021

830

Human fetal lymphoid tissue–inducer cells are interleukin 17–producing precursors to RORC+ CD127+ natural killer–like cells

Tom Cupedo, Natasha K. Crellin, Natalie Papazian,

Nature Immunology

2008

640

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).

Richard E. Champlin, Norbert Schmitz, Mary M. Horowitz,

PubMed

2000

508

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Jan J. Cornelissen, Wim L.J. van Putten, Leo F. Verdonck,

Blood

2007

470

Prevalence and Clinical Symptoms of Human Metapneumovirus Infection in Hospitalized Patients

Bernadette van den Hoogen, Gerard J. J. van Doornum, John C. Fockens,

The Journal of Infectious Diseases

2003

446

Prevention of Epstein-Barr virus–lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

Joost W. J. van Esser, Hubert G.M. Niesters, Bronno van der Holt,

Blood

2002

400

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

Per Ljungman, Marco Bregni, Mats Brune,

Bone Marrow Transplantation

2009

384

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell–depleted SCT

Joost W. J. van Esser, Bronno van der Holt, Ellen Meijer,

Blood

2001

369

Page 1